Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.
Mehta M, Deeksha, Tewari D, Gupta G, Awasthi R, Singh H, Pandey P, Chellappan DK, Wadhwa R, Collet T, Hansbro PM, Kumar SR, Thangavelu L, Negi P, Dua K, Satija S. Mehta M, et al. Among authors: thangavelu l. Chem Biol Interact. 2019 Aug 1;308:206-215. doi: 10.1016/j.cbi.2019.05.028. Epub 2019 May 25. Chem Biol Interact. 2019. PMID: 31136735 Free PMC article. Review.
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.
Sharma P, Mehta M, Dhanjal DS, Kaur S, Gupta G, Singh H, Thangavelu L, Rajeshkumar S, Tambuwala M, Bakshi HA, Chellappan DK, Dua K, Satija S. Sharma P, et al. Among authors: thangavelu l. Chem Biol Interact. 2019 Aug 25;309:108720. doi: 10.1016/j.cbi.2019.06.033. Epub 2019 Jun 18. Chem Biol Interact. 2019. PMID: 31226287 Review.
Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases.
Chellappan DK, Sze Ning QL, Su Min SK, Bin SY, Chern PJ, Shi TP, Ee Mei SW, Yee TH, Qi OJ, Thangavelu L, Rajeshkumar S, Negi P, Chellian J, Wadhwa R, Gupta G, Collet T, Hansbro PM, Dua K. Chellappan DK, et al. Among authors: thangavelu l. Chem Biol Interact. 2019 Sep 1;310:108732. doi: 10.1016/j.cbi.2019.108732. Epub 2019 Jul 2. Chem Biol Interact. 2019. PMID: 31276660 Review.
The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress.
Dua K, Wadhwa R, Singhvi G, Rapalli V, Shukla SD, Shastri MD, Gupta G, Satija S, Mehta M, Khurana N, Awasthi R, Maurya PK, Thangavelu L, S R, Tambuwala MM, Collet T, Hansbro PM, Chellappan DK. Dua K, et al. Among authors: thangavelu l. Drug Dev Res. 2019 Sep;80(6):714-730. doi: 10.1002/ddr.21571. Epub 2019 Jul 16. Drug Dev Res. 2019. PMID: 31691339 Review.
Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update.
Mehta M, Dhanjal DS, Paudel KR, Singh B, Gupta G, Rajeshkumar S, Thangavelu L, Tambuwala MM, Bakshi HA, Chellappan DK, Pandey P, Dureja H, Charbe NB, Singh SK, Shukla SD, Nammi S, Aljabali AA, Wich PR, Hansbro PM, Satija S, Dua K. Mehta M, et al. Among authors: thangavelu l. Inflammopharmacology. 2020 Aug;28(4):795-817. doi: 10.1007/s10787-020-00698-3. Epub 2020 Mar 18. Inflammopharmacology. 2020. PMID: 32189104 Review.
Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities.
Lee LY, Hew GSY, Mehta M, Shukla SD, Satija S, Khurana N, Anand K, Dureja H, Singh SK, Mishra V, Singh PK, Gulati M, Prasher P, Aljabali AAA, Tambuwala MM, Thangavelu L, Panneerselvam J, Gupta G, Zacconi FC, Shastri M, Jha NK, Xenaki D, MacLoughlin R, Oliver BG, Chellappan DK, Dua K. Lee LY, et al. Among authors: thangavelu l. Life Sci. 2021 Feb 15;267:118973. doi: 10.1016/j.lfs.2020.118973. Epub 2021 Jan 2. Life Sci. 2021. PMID: 33400932 Review.
91 results